HCFA "inherent reasonableness" authority
This article was originally published in The Gray Sheet
Executive Summary
General Accounting Office is expected to release by mid-summer a long-awaited report on the Health Care Financing Administration's use of expanded IR authority under Sec. 4316 of the Balanced Budget Act of 1997, Rep. Bill Thomas (R-Calif.) tells a June 15 session of the American Association of Homecare conference in Washington, D.C. Thomas requested GAO to investigate whether HCFA was overstepping the bounds of its IR authority in March 1999. The agency is prohibited from using the expanded IR authority until 90 days after the release of the GAO report under the Balanced Budget Refinement Act of 1999
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.